DHIM supporting immunologic investigations and the identification of immune correlates of protection.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 24872398.
- Also identified by DOI 10.1093/infdis/jiu111 and PMC identifier 4036387.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Evidence suggesting that immune responses to dengue virus (DENV) have the potential for both beneficial and detrimental effects on the outcome of infection is a concern for dengue vaccine development. There is thus a great need to define measures of DENV-specific immune responses that reliably indicate when immunity is protective. The existence of 4 main DENV serotypes and the difficulty in defining which individuals have been exposed and to which viruses present challenges to defining immune correlates of protective immunity against DENV in field efficacy studies; experimental infection studies in humans offer a pathway to address these challenges.
Medical subject headings
- Dengue
- Models, Biological